During insulin-resistant conditions, pathway-specific impairment in PI3K-dependent signaling may cause imbalance between production of nitric oxide (NO) and secretion of endothelin-1 and lead to endothelial dysfunction. The gene discussed is EDN1; the disease is endothelial dysfunction.